In Vitro Diagnostics (IVD) include reagents, instruments, and systems intended for use in the diagnosis of disease or other conditions, including the determination of the state of health, in order to treat or prevent disease. The reagents, instruments and systems are used in the collection, preparation, and examination of specimens taken from the human body. This includes Cardiac Disease, Hematological Disorders, Hormonal Disorders, Metabolic Disorder, Infectious Disease, IVD Analyzers, Oncology and Reproductive Health Diagnostics. Hepatitis B Test Kits are used for the detection of Hepatitis B Virus (HBV), a hepadnavirus that causes acute and chronic liver inflammation. GlobalData uses proprietary data and analytics to provide a comprehensive report on the hepatitis b tests devices market, including market shares of different players within South Africa. Buy the latest report here.
In 2023, GlobalData’s Market Model methodology determined that the leading player in the hepatitis b tests market in South Africa was F. Hoffmann-La Roche followed by Siemens Healthineers, Abbott Laboratories, bioMerieux, Quidelortho, Hologic, Bio-Rad Laboratories and DiaSorin.
Hepatitis B Test Kits comprises Hepatitis B Enzyme Immuno Assay/Enzyme Linked Immunosorbent Assay (EIA/ELISA) Tests and Hepatitis B Nucleic Acid Amplification Tests (NAATs).
The value of the hepatitis b tests devices market within South Africa was expected to be over $3m in 2023.
For the latest complete market share analysis of hepatitis b tests device market in South Africa, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.